000095405 001__ 95405
000095405 005__ 20210902121820.0
000095405 0247_ $$2doi$$a10.2340/00015555-3477
000095405 0248_ $$2sideral$$a119214
000095405 037__ $$aART-2020-119214
000095405 041__ $$aeng
000095405 100__ $$aSampogna, F.
000095405 245__ $$aExploring the EQ-5D dimension of pain/discomfort in dermatology outpatients from a multicentre study in 13 European countries
000095405 260__ $$c2020
000095405 5060_ $$aAccess copy available to the general public$$fUnrestricted
000095405 5203_ $$aPain and discomfort are important symptoms in dermatology. The aim of this cross-sectional, multicentre study was to describe the prevalence of pain/discomfort and its associations in patients with several dermatological conditions across 13 European countries. The outcome was the prevalence of pain/discomfort according to a question of the EQ-5D questionnaire. Data collected from November 2011 to February 2013 were complete for 3, 509 consecutive outpatients. Moderate or extreme pain/discomfort was reported by 55.5% of patients and 31.5% of controls with no skin conditions. The highest proportions were reported by patients with hidradenitis suppurativa (92.9%), leg ulcer (81.4%), prurigo (80%) and lichen planus (75.6%). Pain/discomfort was associated with older age, low educational level, clinical severity, flare on scalp or hands, itch, depression, anxiety, low quality of life, and thoughts of suicide. It is important to enquire specifically about pain/discomfort during clinical consultations and to address it when planning a patient’s care.
000095405 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000095405 590__ $$a4.437$$b2020
000095405 591__ $$aDERMATOLOGY$$b15 / 68 = 0.221$$c2020$$dQ1$$eT1
000095405 592__ $$a0.981$$b2020
000095405 593__ $$aMedicine (miscellaneous)$$c2020$$dQ1
000095405 593__ $$aDermatology$$c2020$$dQ1
000095405 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000095405 700__ $$aAbeni, D.
000095405 700__ $$aGieler, U.
000095405 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, L.$$uUniversidad de Zaragoza
000095405 700__ $$aLien, L.
000095405 700__ $$aPoot, F.
000095405 700__ $$aJemec, G.B.E.
000095405 700__ $$aSzabo, C.
000095405 700__ $$aLinder, D.
000095405 700__ $$aVAN MIDDENDORP, H.
000095405 700__ $$aHalvorsen, J.A.
000095405 700__ $$aBalieva, F.
000095405 700__ $$aSzepietowski, J.C.
000095405 700__ $$aRomanov, D.V.
000095405 700__ $$0(orcid)0000-0001-5632-0351$$aMarron, S.E.$$uUniversidad de Zaragoza
000095405 700__ $$aAltunay, I.K.
000095405 700__ $$aFinlay, A.Y.
000095405 700__ $$aSalek, S.S.
000095405 700__ $$aKupfer, J.
000095405 700__ $$aMisery, L.
000095405 700__ $$aDalgard, F.J.
000095405 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000095405 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000095405 773__ $$g100, 8 (2020), 1-6$$pActa derm.-venereol.$$tACTA DERMATO-VENEREOLOGICA$$x0001-5555
000095405 8564_ $$s2369256$$uhttps://zaguan.unizar.es/record/95405/files/texto_completo.pdf$$yVersión publicada
000095405 8564_ $$s734340$$uhttps://zaguan.unizar.es/record/95405/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000095405 909CO $$ooai:zaguan.unizar.es:95405$$particulos$$pdriver
000095405 951__ $$a2021-09-02-10:07:17
000095405 980__ $$aARTICLE